The role of EMT in renal fibrosis

Cell and Tissue Research

Volumn 347, Issue 1, 2012, Pages 103-116

  Carew, Rosemarie M ^a   Wang, Bo ^a   Kantharidis, Phillip ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Diabetic nephropathy; EMT; MicroRNA; Renal fibrosis; TGF beta

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA CADHERIN; CADHERIN; CALCIUM CHANNEL BLOCKING AGENT; CALVASCULIN; CELL PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRONECTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KALININ; LAMININ 1; MATRIX METALLOPROTEINASE INHIBITOR; MICRORNA; MICRORNA 200; MICRORNA 21; MICRORNA 29; NERVE CELL ADHESION MOLECULE; OB CADHERIN; PARICALCITOL; PYRIDOXAMINE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA2; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3; RUBOXISTAURIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; ZEB1 PROTEIN; ZEB2 PROTEIN;

BINDING AFFINITY; BINDING SITE; DIABETIC NEUROPATHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL MODEL; FIBROGENESIS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; UPREGULATION; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84858308320     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-011-1227-1     Document Type: Review

References (178)

1. Abreu JG, Ketpura NI, Reversade B, De Robertis EM (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4:599-604
2. Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119:1438-1449
3. Aresu L, Benali S, Garbisa S, Gallo E, Castagnaro M (2011) Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition. Histol Histopath 26:307-313
4. Badid C, Desmouliere A, Babici D, Hadj-Aissa A, McGregor B, Lefrancois N, Touraine JL, Laville M (2002) Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Nephrol Dial Transplant 17:1993-1998 (Pubitemid 35277100)
5. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-36810 (Pubitemid 32002090)
6. Barrallo-Gimeno A, Nieto MA (2005) The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132:3151-3161 (Pubitemid 41167144)
7. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL (2001) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27-36 (Pubitemid 32060576)
8. Bienz M (2005) beta-Catenin: a pivot between cell adhesion and Wnt signalling. Curr Biol 15:R64-67
9. Border WA, Yamamoto T, Noble NA (1996) Transforming growth factor beta in diabetic nephropathy. Diabetes Metab Rev 12:309-339 (Pubitemid 27062225)
10. Boutet A, De Frutos CA, Maxwell PH, Mayol MJ, Romero J, Nieto MA (2006) Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25:5603-5613 (Pubitemid 44847200)
11. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
12. Burney BO, Kalaitzidis RG, Bakris GL (2009) Novel therapies of diabetic nephropathy. Curr Opin Nephrol Hypertens 18:107-111
13. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME, Kantharidis P (2006) Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 17:2484-2494 (Pubitemid 44300964)
14. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biol 2:76-83
15. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 99:12877-12882
16. Cheng S, Lovett DH (2003) Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 162:1937-1949 (Pubitemid 36613051)
17. Cho HJ, Baek KE, Saika S, Jeong MJ, Yoo J (2007) Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun 353:337-343 (Pubitemid 46014570)
18. Chung AC, Huang XR, Meng X, Lan HY (2010) miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 21:1317-1325
19. Colwell AS, Longaker MT, Lorenz HP (2005) Mammalian fetal organ regeneration. Adv Biochem Eng Biotechnol 93:83-100 (Pubitemid 44617148)
20. Cooper ME, Gilbert RE (2003) Pathogenesis, prevention, and treatment of diabetic nephropathy. In: Johnson RJ, Feehally J (eds) Comprehensive clinical nephrology. Mosby, Philadelphia, pp 439-451
21. De Albuquerque DA, Saxena V, Adams DE, Boivin GP, Brunner HI, Witte DP, Singh RR (2004) An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. Kidney Int 65:846-859 (Pubitemid 38251060)
22. De Laplanche E, Gouget K, Cleris G, Dragounoff F, Demont J, Morales A, Bezin L, Godinot C, Perriere G, Mouchiroud D et al (2006) Physiological oxygenation status is required for fully differentiated phenotype in kidney cortex proximal tubules. Am J Physiol Renal Physiol 291:F750-760 (Pubitemid 44506971)
23. Dolan V, Murphy M, Sadlier D, Lappin D, Doran P, Godson C, Martin F, O'Meara Y, Schmid H, Henger A et al (2005) Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis 45:1034-1039 (Pubitemid 40806516)
24. Dressler GR (2006) The cellular basis of kidney development. Annu Rev Cell Dev Biol 22:509-529
25. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY (1999) Transforming growth factor-beta regulates tubular epithelial- myofibroblast transdifferentiation in vitro. Kidney Int 56:1455-1467 (Pubitemid 29451252)
26. Fan JM, Huang XR, Ng YY, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY (2001) Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 37:820-831 (Pubitemid 32268044)
27. Franke WW, Schmid E, Osborn M, Weber K (1978) Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci USA 75:5034-5038 (Pubitemid 9056332)
28. Gagliardini E, Benigni A (2006) Role of anti-TGF-beta antibodies in the treatment of renal injury. Cytokine Growth Factor Rev 17:89-96 (Pubitemid 43117518)
29. Galichon P, Hertig A (2011) Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside? Fibrogenesis Tissue Repair 4:11
30. Gilbert RE, Cooper ME (1999) The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56:1627-1637 (Pubitemid 29518163)
31. Gomez-Alamillo C, Benito-Hernandez A, Ramos-Barron MA, Agueros C, Rodrigo E, Ruiz JC, Sanchez M, San Cosme L, Arias M (2010) Analysis of urinary gene expression of epithelial-mesenchymal transition markers in kidney transplant recipients. Transplant Proc 42:2886-2888
32. Gore-Hyer E, Shegogue D, Markiewicz M, Lo S, Hazen-Martin D, Greene EL, Grotendorst G, Trojanowska M (2002) TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 283:F707-716 (Pubitemid 35033958)
33. Goumenos DS, Brown CB, Shortland J, El Nahas AM (1994) Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 9:1418-1425 (Pubitemid 24310284)
34. Greenburg G, Hay ED (1982) Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 95:333-339 (Pubitemid 13197104)
35. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ (2008a) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593-601 (Pubitemid 351627379)
36. Gregory PA, Bracken CP, Bert AG, Goodall GJ (2008b) MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 7:3112-3118
37. Grgic I, Duffield JS, Humphreys BD (2011) The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol (in press)
38. Gupta S, Clarkson MR, Duggan J, Brady HR (2000) Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58:1389-1399
39. Halawa B (1998) Combination therapy in primary hypertension. Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 4:35-38
40. Hay ED (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233:706-720
41. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW (1999) TGFbeta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int 56:1710-1720 (Pubitemid 29518171)
42. He W, Kang YS, Dai C, Liu Y (2011) Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22:90-103
43. Hill C, Flyvbjerg A, Gronbaek H, Petrik J, Hill DJ, Thomas CR, Sheppard MC, Logan A (2000) The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology 141:1196-1208 (Pubitemid 32260463)
44. Hill C, Flyvbjerg A, Rasch R, Bak M, Logan A (2001) Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. J Endocrinol 170:647-651 (Pubitemid 32834331)
45. Hills CE, Brunskill NJ (2009) Cellular and physiological effects of Cpeptide. Clin Sci (Lond) 116:565-574
46. Holian J, Qi W, Kelly DJ, Zhang Y, Mreich E, Pollock CA, Chen XM (2008) Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells. Am J Physiol Renal Physiol 295:F1388-1396
47. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85-97
48. Hynes RO, Yamada KM (1982) Fibronectins: multifunctional modular glycoproteins. J Cell Biol 95:369-377 (Pubitemid 13215850)
49. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R (1998) Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861 (Pubitemid 28155657)
50. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350 (Pubitemid 34847966)
51. Jamora C, Lee P, Kocieniewski P, Azhar M, Hosokawa R, Chai Y, Fuchs E (2005) A signaling pathway involving TGF-beta2 and snail in hair follicle morphogenesis. PLoS Biol 3:e11
52. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grunert S (2002) Ras and TGF{beta} cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156:299-314
53. Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784 (Pubitemid 38063698)
54. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428
55. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392-401
56. Kato M, Wang L, Putta S, Wang M, Yuan H, Sun G, Lanting L, Todorov I, Rossi JJ, Natarajan R. Post-transcriptional upregulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells. J Biol Chem 285:34004-34015
57. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, Natarajan R (2007) MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 104:3432-3437 (Pubitemid 46364176)
58. Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I et al (2009) TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11:881-889
59. Kattla JJ, Carew RM, Heljic M, Godson C, Brazil DP (2008) Protein kinase B/Akt activity is involved in renal TGF{beta}-1 driven epithelial-mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol 295:F215-F225
60. Khokha MK, Hsu D, Brunet LJ, Dionne MS, Harland RM (2003) Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet 34:303-307 (Pubitemid 36792863)
61. Kim K, Lu Z, Hay ED (2002a) Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26:463-476 (Pubitemid 34762099)
62. Kim K, Lu Z, Hay ED (2002b) Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 26:463-476 (Pubitemid 34762099)
63. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103:13180-13185 (Pubitemid 44338936)
64. Korpal M, Lee ES, Hu G, Kang Y (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283:14910-14914
65. Koseki C, Herzlinger D, al-Awqati Q (1992) Apoptosis in metanephric development. J Cell Biol 119:1327-1333
66. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D (2010) Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 21:438-447
67. Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME et al (2004) Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products. J Am Soc Nephrol 15:2125-2138 (Pubitemid 39031351)
68. Lassila M, Jandeleit-Dahm K, Seah KK, Smith CM, Calkin AC, Allen TJ, Cooper ME (2005) Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J Am Soc Nephrol 16:363-373 (Pubitemid 41725131)
69. Leask A (2010) Targeting the jagged/notch pathway: a new treatment for fibrosis? J Cell Commun Signal 4:197-198
70. Ledbetter S, Kurtzberg L, Doyle S, Pratt BM (2000) Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2. Kidney Int 58:2367-2376
71. Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial- mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172:973-981
72. Leroy P, Mostov KE (2007) Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol Biol Cell 18:1943-1952 (Pubitemid 46717573)
73. Li X, Talts U, Talts JF, Arman E, Ekblom P, Lonai P (2001) Akt/PKB regulates laminin and collagen IV isotypes of the basement membrane. Proc Natl Acad Sci USA 98:14416-14421 (Pubitemid 33121406)
74. Li Y, Yang J, Dai C, Wu C, Liu Y (2003) Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Investig 112:503-516 (Pubitemid 38056335)
75. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y (2008) Epithelial-to- mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172:299-308 (Pubitemid 351282018)
76. Liu Y (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15:1-12
77. Liu Y, Taylor NE, Lu L, Usa K, Cowley AW, Jr, Ferreri NR, Yeo NC, Liang M (2010) Renal medullary microRNAs in Dahl saltsensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55:974-982
78. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA (2007) Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 104:10069-10074 (Pubitemid 47175264)
79. Mason RM, Wahab NA (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358-1373 (Pubitemid 36519197)
80. Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC et al (2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361:40-51
81. McMahon R, Murphy M, Clarkson M, Taal M, Mackenzie HS, Godson C, Martin F, Brady HR (2000) IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J Biol Chem 275:9901-9904 (Pubitemid 30202033)
82. Mitu G, Hirschberg R (2008) Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Front Biosci 13:4726-4739 (Pubitemid 351589193)
83. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S (2002) Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13(Suppl 1):S14-21 (Pubitemid 34008173)
84. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR (1999) Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274:5830-5834 (Pubitemid 29109239)
85. Nath KA (1992) Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17
86. Neilson EG (2006) Mechanisms of disease: Fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2:101-108
87. Neilson EG (2007) Plasticity, nuclear diapause, and a requiem for the terminal differentiation of epithelia. J Am Soc Nephrol 18:1995-1998
88. Neilson EG (2010) The Jeremiah Metzger lecture. The origin of fibroblasts and the terminality of epithelial differentiation. Trans Am Clin Climatol Assoc 121:240-250, The Jeremiah Metzger lecture
89. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY (1998) Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54:864-876 (Pubitemid 28397404)
90. Nishikawa T, Edelstein D, Brownlee M (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 77:S26-30
91. Nyhan KC, Faherty N, Murray G, Cooey LB, Godson C, Crean JK, Brazil DP (2010) Jagged/Notch signalling is required for a subset of TGFbeta1 responses in human kidney epithelial cells. Biochim Biophys Acta 1803:1386-1395
92. Okada H, Danoff TM, Kalluri R, Neilson EG (1997) Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 273:F563-574
93. Okada H, Ban S, Nagao S, Takahashi H, Suzuki H, Neilson EG (2000a) Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 58:587-597 (Pubitemid 30620008)
94. Okada H, Inoue T, Suzuki H, Strutz F, Neilson EG (2000b) Epithelial-mesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. Nephrol Dial Transplant 15(Suppl 6):44-46
95. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME (2001) Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108:1853-1863 (Pubitemid 34015131)
96. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894-907 (Pubitemid 351482843)
97. Peinado H, Quintanilla M, Cano A (2003) Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 278:21113-21123 (Pubitemid 36806424)
98. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415-428 (Pubitemid 46809165)
99. Phanish MK, Wahab NA, Colville-Nash P, Hendry BM, Dockrell ME (2006) The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J 393:601-607 (Pubitemid 43099100)
100. Potenta S, Zeisberg E, Kalluri R (2008) The role of endothelial-to- mesenchymal transition in cancer progression. Br J Cancer 99:1375-1379
101. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277:C1-9
102. Qi W, Twigg S, Chen X, Polhill TS, Poronnik P, Gilbert RE, Pollock CA (2005) Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis. Am J Physiol Renal Physiol 288:F800-F809 (Pubitemid 40381749)
103. Qi W, Chen X, Holian J, Mreich E, Twigg S, Gilbert RE, Pollock CA (2006a) Transforming growth factor-beta1 differentially mediates fibronectin and inflammatory cytokine expression in kidney tubular cells. Am J Physiol Renal Physiol 291:F1070-F1077 (Pubitemid 44772040)
104. Qi W, Chen X, Twigg S, Polhill TS, Gilbert RE, Pollock CA (2006b) Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney Int 69:989-995 (Pubitemid 43372173)
105. Qi W, Chen X, Poronnik P, Pollock CA (2008) Transforming growth factor-beta/connective tissue growth factor axis in the kidney. Int J Biochem Cell Biol 40:9-13 (Pubitemid 350064576)
106. Qin W, Chi-Kong A, Huang XR, Meng X, Lan HY (2010) miR-29 inhibits TGF-beta/Smad3-mediated renal fibrosis in vitro and in vivo. 43rd Annual Meeting of the American Society of Nephrology (Denver, Colorado)
107. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G, D'Amico G (2002) Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62:137-146 (Pubitemid 34754056)
108. Reese S, Vidyasagar A, Jacobson L, Acun Z, Esnault S, Hullett D,Malter JS, Djamali A (2010) The Pin 1 inhibitor juglone attenuates kidney fibrogenesis via Pin 1-independent mechanisms in the unilateral ureteral occlusion model. Fibrogenesis Tissue Repair 3:1
109. Reeves WB, Andreoli TE (2000) Transforming growth factor beta contributes to progressive diabetic nephropathy. Proc Natl Acad Sci USA 97:7667-7669 (Pubitemid 30460701)
110. Rinn JL, Bondre C, Gladstone HB, Brown PO, Chang HY (2006) Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genetics 2:e119
111. Roberts AB (1998) Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111-119
112. Roberts AB, Sporn MB (1993) Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8:1-9 (Pubitemid 23093206)
113. Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam LJ (1997) Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 50:123-127 (Pubitemid 27093027)
114. Rodgers K, McMahon B, Mitchell D, Sadlier D, Godson C (2005) Lipoxin A4 modifies platelet-derived growth factor-induced profibrotic gene expression in human renal mesangial cells. Am J Pathol 167:683-694 (Pubitemid 41216354)
115. Runyan CE, Schnaper HW, Poncelet AC (2004) The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 279:2632-2639 (Pubitemid 38114250)
116. Saad S, Stanners SR, Yong R, Tang O, Pollock CA (2010) Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor. Int J Biochem Cell Biol 42:1115-1122
117. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T (1997) TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124:2659-2670 (Pubitemid 27341765)
118. Schena FP, Gesualdo L (2005) Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16(Suppl 1):S30-33 (Pubitemid 41725079)
119. Scherer A, Gwinner W, Mengel M, Kirsch T, Raulf F, Szustakowski, JD, Hartmann N, Staedtler F, Engel G, Klupp J et al. (2009) Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 24:2567-2575
120. Schramek H, Feifel E, Marschitz I, Golochtchapova N, Gstraunthaler G, Montesano R (2003) Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells. Am J Physiol Cell Physiol 285:C652-661 (Pubitemid 37022064)
121. Sharma K, Ziyadeh FN (1995) Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146
122. Sharma K, Jin Y, Guo J, Ziyadeh FN (1996) Neutralization of TGFbeta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530
123. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BR, Kurnik PB, Weisberg LS (1997) Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 46:854-859 (Pubitemid 27188264)
124. Shook D, Keller R (2003) Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 120:1351-1383 (Pubitemid 37421168)
125. Slattery C, Campbell E, McMorrow T, Ryan MP (2005) Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. Am J Pathol 167:395-407 (Pubitemid 43026096)
126. Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner AM, Dooley S (2000) Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. The TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J Biol Chem 275:29308-29317 (Pubitemid 32043801)
127. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG (1995) Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405
128. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, Neilson EG (2002) Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61:1714-1728 (Pubitemid 34437925)
129. Sugimoto H, Grahovac G, Zeisberg M, Kalluri R (2007) Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 56:1825-1833 (Pubitemid 47025452)
130. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, Nagayama M (2003) Down-regulation of Wnt-4 and up-regulation of Wnt- 5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 94:593-597 (Pubitemid 36975013)
131. Usui H, Shikata K, Matsuda M, Okada S, Ogawa D, Yamashita T, Hida K, Satoh M, Wada J, Makino H (2003) HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant 18:265-272 (Pubitemid 36181675)
132. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A (2005) TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 16:1987-2002 (Pubitemid 40471965)
133. Venkov CD, Link AJ, Jennings JL, Plieth D, Inoue T, Nagai K, Xu C, Dimitrova YN, Rauscher FJ, Neilson EG (2007) A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest 117:482-491 (Pubitemid 46203977)
134. Vogel W, Gish GD, Alves F, Pawson T (1997) The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1:13-23 (Pubitemid 127376389)
135. Vongwiwatana A, Tasanarong A, Rayner DC, Melk A, Halloran PF (2005) Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant 5:1367-1374 (Pubitemid 40839427)
136. Wahab NA, Yevdokimova N, Weston BS, Roberts T, Li XJ, Brinkman H, Mason RM (2001) Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359:77-87 (Pubitemid 32939209)
137. Walsh DW, Roxburgh SA, McGettigan P, Berthier CC, Higgins DG, Kretzler M, Cohen CD, Mezzano S, Brazil DP, Martin F (2008) Co-regulation of Gremlin and Notch signalling in diabetic nephropathy. Biochim Biophys Acta 1782:10-21
138. Wang S, Denichilo M, Brubaker C, Hirschberg R (2001) Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 60:96-105 (Pubitemid 32587544)
139. Wang X, Zheng M, Liu G, Xia W, McKeown-Longo PJ, Hung MC, Zhao J (2007) Kruppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res 67:7184-7193 (Pubitemid 47206546)
140. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X, Quigg RJ (2008) MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 22:4126-4135
141. Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, Cooper ME et al (2010a) E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 59:1794-1802
142. Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, Szeto CC (2010b) Intrarenal expression of microRNAs in patients with IgA nephropathy. Lab Invest 90:98-103
143. Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, Szeto CC (2010c) Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens 23:78-84
144. Wang B, Koh P, Winbanks C, Coughlan MT, McClelland A, Watson A, Jandeleit-Dahm K, Burns WC, Thomas MC, Cooper ME et al (2011) miR-200a prevents renal fibrogenesis through repression of TGF-{beta}2 expression. Diabetes 60:280-287
145. Xin X, Chen S, Khan ZA, Chakrabarti S (2007) Akt activation and augmented fibronectin production in hyperhexosemia. Am J Physiol Endocrinol Metab 293:E1036-1044 (Pubitemid 47535835)
146. Xue C, Plieth D, Venkov C, Xu C, Neilson EG (2003) The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 63:3386-3394 (Pubitemid 36735899)
147. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA (1993) Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818 (Pubitemid 23069947)
148. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA (1996) Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49:461-469 (Pubitemid 26050323)
149. Yamamoto T, Watanabe T, Ikegaya N, Fujigaki Y, Matsui K, Masaoka H, Nagase M, Hishida A (1998) Expression of types I, II, and III TGF-beta receptors in human glomerulonephritis. J Am Soc Nephrol 9:2253-2261 (Pubitemid 28543803)
150. Yang J, Liu Y (2001) Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159:1465-1475 (Pubitemid 32947976)
151. Yang J, Liu Y (2002) Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13:96-107 (Pubitemid 34042016)
152. Yang J, Dai C, Liu Y (2001) Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther 8:1470-1479 (Pubitemid 32994658)
153. Yang J, Dai C, Liu Y (2002a) Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 13:2464-2477
154. Yang J, Shultz RW, Mars WM, Wegner RE, Li Y, Dai C, Nejak K, Liu Y (2002b) Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110:1525-1538 (Pubitemid 35396923)
155. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939 (Pubitemid 38798858)
156. Yokoi H, Sugawara A, Mukoyama M, Mori K, Makino H, Suganami T, Nagae T, Yahata K, Fujinaga Y, Tanaka I et al (2001) Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. Am J Kidney Dis 38:S134-138 (Pubitemid 32927628)
157. Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M et al (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15:1430-1440 (Pubitemid 38679668)
158. Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH, Cha SY, Ryu JK, Choi YJ, Kim J et al (2006) A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 8:1398-1406 (Pubitemid 44835115)
159. Yu L, Border WA, Huang Y, Noble NA (2003) TGF-beta isoforms in renal fibrogenesis. Kidney Int 64:844-856
160. Yu W, Kamara H, Svoboda KK (2008) The role of twist during palate development. Dev Dyn 237:2716-2725
161. Zavadil J, Bottinger EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24:5764-5774
162. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 23:1155-1165 (Pubitemid 38436879)
163. Zavadil J, Narasimhan M, Blumenberg M, Schneider RJ (2007) Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 185:157-161 (Pubitemid 46956856)
164. Zeisberg M, Duffield JS (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247-1253
165. Zeisberg M, Kalluri R (2004) The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 82:175-181 (Pubitemid 38392167)
166. Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119:1429-1437
167. Zeisberg M, Bonner G, Maeshima Y, Colorado P, Muller GA, Strutz F, Kalluri R (2001a) Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 159:1313-1321 (Pubitemid 32947961)
168. Zeisberg M, Strutz F, Muller GA (2001b) Renal fibrosis: an update. Curr Opin Nephrol Hypertens 10:315-320 (Pubitemid 32424018)
169. Zeisberg M, Maeshima Y, Mosterman B, Kalluri R (2002) Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am J Pathol 160:2001-2008 (Pubitemid 34663393)
170. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Muller GA, Kalluri R (2003a) Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285:F1060-1067 (Pubitemid 37421041)
171. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R (2003b) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Med 9:964-968 (Pubitemid 36889942)
172. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB et al (2007a) Endothelial-to- mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952-961 (Pubitemid 47222040)
173. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R (2007b) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282:23337-23347 (Pubitemid 47311952)
174. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19:2282-2287
175. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC (2008) Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 105:15896-15901
176. Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G, Chen Y, Zhang Z, Strugnell S, Sabbagh Y et al (2009) Long-term therapeutic effect of vitamin d analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol 297:F791-801
177. Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15(Suppl 1):S55-57
178. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97:8015-8020 (Pubitemid 30460765)